International Journal of Cardiology
Volume 65, Issue 1 , Pages 75-80 , 1 June 1998

Gender differences in baseline variables, therapies and outcomes in Chinese patients with acute myocardial infarction

Received 27 November 1997 ,Revised 26 March 1998 ,Accepted 26 March 1998.

References 

  1. Word Health Organization. Myocardial infarction community registers. Public health in Europe. No. 5. Copenhagen: Regional Office for Europe, WHO, 1976.
  2. Puletti M, Sunseri L, Curione M, Erba SM, Borgia C. Acute myocardial infarction: sex-related differences in prognosis. Am Heart J. 1984;108:63–66
  3. Dittrich J, Gilpin E, Nicod P, Cali G, Henning H, Ros J. Acute myocardial infarction in women: influence of gender on mortality and prognostic variables. Am J Cardiol. 1988;62:1–7
  4. Fiebach NH, Viscoli CM, Horwitz RI. Differences between women and men in survival after myocardial infarction: biology or methodology?. JAMA. 1990;263:1092–1096
  5. Greenland P, Reicher-Reiss H, Goldbourt U, Behar S. In-hospital and 1-year mortality in 1524 women after myocardial infarction: comparison with 4315 men. Circulation. 1991;83:484–491
  6. Tofler GH, Stone PH, Muller JE, et al.  Effects of gender and race on prognosis after myocardial infarction: at first prognosis in one particular black woman. J Am Coll Cardiol. 1987;9:473–482
  7. Lerner DJ, Kannel WB. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J. 1986;111:383–390
  8. Strokes JS, Kannel WB, Wolf PA, Cupples AL, D'Agostin RB. The relative importance of selected risk factors for various manifestations of cardiovascular disease among men and women from 35 to 64 years old: 30 years of follow-up in the Framingham. Circulation. 1987;75:465–473
  9. Anderson KM, Silson PW, Odelll PM, Kannel WB. An undated coronary profile: a statement of health professionals. Circulation. 1991;83:356–362
  10. Meilahn EN, Becker RC, Corrao JM. Primary prevention of coronary heart disease in women. Cardiology. 1995;86:286–298
  11. Robinson K, Conroy RM, Mulcahy R, Hickey N. Risk factors and in-hospital course of first episode of myocardial infarction or acute coronary insufficiency in women. J Am Coll Cardiol. 1988;11:932–936
  12. Murabito JM, Evans JC, Larson MG, Levy D. Prognosis after the onset of coronary heart disease: an investigation of differences in outcome between the sexes according to initial coronary disease presentation. Circulation. 1993;88:2548–2555
  13. Mendelson MA, Hendel RC. Myocardial infarction in women. Cardiology. 1995;86:272–285
  14. Chaitman BR, Bourassa MG, Davis K, et al.  Angiographic prevalence of high-risk coronary artery disease in patient subsets (CASS). Circulation. 1981;64:360–367
  15. Kennedy JW, Killip T, Fisher LD, Alderman EL, Gillespie MJ, Mock MB. The clinical spectrum of coronary artery disease and its surgical and medical management, 1974–1979: the coronary artery surgery study.. Circulation. 1982;66(S III):16–23
  16. Abbott RD, Donahue RP, Kannel WB, Wilson PW. The impact of diabetes on survival following myocardial infarction in men versus women: the Framingham study. JAMA. 1988;260:3456–3460
  17. Manson JE, Colditz GA, Stampger MJ, et al.  A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Int Med. 1991;151:1141–1147
  18. Kwiterovich PO, Coresh J, Smith HH, Bachorik PS, Derby CA, Pearson TA. Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease. Am J Cardiol. 1992;69:1015–1021
  19. Pierce JP, Fiore MC, Novotny TE, Hatziandreu EJ, Davis RM. Trends in cigarette smoking in the United States: projections to the year 2000. JAMA. 1989;261:3007–3012
  20. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease: I. treatments following myocardial infraction. JAMA. 1988;260:2088–2093
  21. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease: II. unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA. 1988;260:2259–2263
  22. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397–402.
  23. AIMS Trial study Group. Effect of intravenous APSEC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1988;1:842–7.
  24. Wilcox RG, von der Lippe G, Olsson CG, Jensen G, Skene AM, Hampton JR. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction: Anglo-Scandinavian study of early thrombolysis (ASSET). Lancet. 1988;2:525–530
  25. Tsuyuki RT, Teo KT, Ikuta RM, Bay KS, Greenwood PV, Montague TJ. Mortality risk and patterns of practicing 2070 patients with acute myocardial infarction, 1987–92: relative importance of age, sex and medical therapy. Chest. 1994;105:1687–1692
  26. Henning R. Swedish Cooperative CCU Study. Acta Med Scand. 1975;586(suppl):1–63
  27. Greenland P, Reicher-Reiss H, Goldbourt U, Behar S. Israeli SPRINT Investigators in-hospital and 1-year mortality in 1524 women after myocardial infarction— comparison with 4,315 men. Circulation. 1991;83:484–491
  28. McGovern PG, Folsom AR, Sprafka JM, et al.  Trends in survival hospitalized myocardial infarction patients between 1970 and 1985: the Minnesota heart survey.. Circulation. 1992;85:172–179

PII: S0167-5273(98)00094-1

International Journal of Cardiology
Volume 65, Issue 1 , Pages 75-80 , 1 June 1998

Article Tools